"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","growth_protocol_ch1","molecule_ch1","extract_protocol_ch1","extract_protocol_ch1.1","taxid_ch1","description","data_processing","data_processing.1","data_processing.2","data_processing.3","data_processing.4","platform_id","contact_name","contact_email","contact_phone","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","data_row_count","instrument_model","library_selection","library_source","library_strategy","relation","relation.1","supplementary_file_1","fraction:ch1","tissue:ch1"
"GSM3741565","X1: benign thyriod nodule","GSM3741565","Public on May 01 2019","Apr 30 2019","May 15 2019","SRA","1","plasma","Homo sapiens","tissue: benign thyriod nodule","fraction: circulating exosomes","plasma exosomal RNA was isolated from petient with benign thyriod nodule, metiastatic thyroid cancer, non-metastatic thyroid cancer, and healty individuals.","total RNA","The miRNAs were extracted from plasma-isolated exosomes using the miRNeasy Micro Kit per the manufacturer’s protocol","Small RNA libraries were constructed as instructed by the NEBNext Multiplex Small RNA Library Prep Set for Illumina (NEB, Ipswich, MA, USA) with minor modifications. Ten ng of small RNA were used as the starting material. After sequential ligation of the Multiplex 3’ SR Adaptor, hybridization of the reverse transcription primer, and ligation of the Multiplex 5’ SR Adaptor, the RNA-Adaptor complex was reversed transcribed into cDNA. Then the small RNA libraries were amplified and the Illumina compatible Index Primers were incorporated with 10 cycles of PCR amplification. The amplified libraries were resolved on a native 5% acrylamide gel (Bio-rad, Hercules, CA). DNA fragments corresponding to 140 - 160 bp (the size comprising the miRNA inserts plus the 3’ and 5’ adaptors) were recovered in 12 μL of Elution Buffer (QIAGEN) and determined with High Sensitivity DNA Chip on Agilent 2100 bioanalyzer. Absolute quantities of each indexed library were determined by real time qPCR using KAPA Library Quantification Kit according to the manufacture’s protocol.","9606","miRNA","The clustering of the index-coded samples was performed on a cBot Cluster Generation System using TruSeq SR Cluster Kit v3-cBot-HS (Illumia).","After cluster generation, the libraries were sequenced and 50bp single-end reads were generated.","The raw data (raw reads) extracted from FASTQ files were firstly processed through perl and python scripts. In this step, clean data(clean reads) were generated by removing reads containing ploy-N, with 5’ adapter contaminants, without 3’ adapter or the insert tag, containing ploy A or T or G or C and low quality reads from raw data.","Then the clean data were aligned against human miRNA sequences from miRBase (Release 20) and NCBI human genome reference sequences (Release 103) using Bowtie (version 0.12.8) .","miRNA profiling was normalized using read counts of a specific miRNA per million(TPM) mappable miRNA sequences. To find novel miRNAs, the raw data was independently processed by combined use of miRDeep 2 and miREvo. Predicted miRNAs with scores ≥ 2 were considered significant.","GPL11154","Xiaoyi,,Huang","harbinner@hotmail.com","86-451-86298745","Harbin Medical University Cancer Hospital","Haping Road 150","Harbin","Heilongjiang","150081","China","0","Illumina HiSeq 2000","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11539274","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5771419","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3741nnn/GSM3741565/suppl/GSM3741565_X1_clean.fa.gz","circulating exosomes","benign thyriod nodule"
"GSM3741566","X2: benign thyriod nodule","GSM3741566","Public on May 01 2019","Apr 30 2019","May 15 2019","SRA","1","plasma","Homo sapiens","tissue: benign thyriod nodule","fraction: circulating exosomes","plasma exosomal RNA was isolated from petient with benign thyriod nodule, metiastatic thyroid cancer, non-metastatic thyroid cancer, and healty individuals.","total RNA","The miRNAs were extracted from plasma-isolated exosomes using the miRNeasy Micro Kit per the manufacturer’s protocol","Small RNA libraries were constructed as instructed by the NEBNext Multiplex Small RNA Library Prep Set for Illumina (NEB, Ipswich, MA, USA) with minor modifications. Ten ng of small RNA were used as the starting material. After sequential ligation of the Multiplex 3’ SR Adaptor, hybridization of the reverse transcription primer, and ligation of the Multiplex 5’ SR Adaptor, the RNA-Adaptor complex was reversed transcribed into cDNA. Then the small RNA libraries were amplified and the Illumina compatible Index Primers were incorporated with 10 cycles of PCR amplification. The amplified libraries were resolved on a native 5% acrylamide gel (Bio-rad, Hercules, CA). DNA fragments corresponding to 140 - 160 bp (the size comprising the miRNA inserts plus the 3’ and 5’ adaptors) were recovered in 12 μL of Elution Buffer (QIAGEN) and determined with High Sensitivity DNA Chip on Agilent 2100 bioanalyzer. Absolute quantities of each indexed library were determined by real time qPCR using KAPA Library Quantification Kit according to the manufacture’s protocol.","9606","miRNA","The clustering of the index-coded samples was performed on a cBot Cluster Generation System using TruSeq SR Cluster Kit v3-cBot-HS (Illumia).","After cluster generation, the libraries were sequenced and 50bp single-end reads were generated.","The raw data (raw reads) extracted from FASTQ files were firstly processed through perl and python scripts. In this step, clean data(clean reads) were generated by removing reads containing ploy-N, with 5’ adapter contaminants, without 3’ adapter or the insert tag, containing ploy A or T or G or C and low quality reads from raw data.","Then the clean data were aligned against human miRNA sequences from miRBase (Release 20) and NCBI human genome reference sequences (Release 103) using Bowtie (version 0.12.8) .","miRNA profiling was normalized using read counts of a specific miRNA per million(TPM) mappable miRNA sequences. To find novel miRNAs, the raw data was independently processed by combined use of miRDeep 2 and miREvo. Predicted miRNAs with scores ≥ 2 were considered significant.","GPL11154","Xiaoyi,,Huang","harbinner@hotmail.com","86-451-86298745","Harbin Medical University Cancer Hospital","Haping Road 150","Harbin","Heilongjiang","150081","China","0","Illumina HiSeq 2000","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11539273","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5771420","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3741nnn/GSM3741566/suppl/GSM3741566_X2_clean.fa.gz","circulating exosomes","benign thyriod nodule"
"GSM3741567","X3: benign thyriod nodule","GSM3741567","Public on May 01 2019","Apr 30 2019","May 15 2019","SRA","1","plasma","Homo sapiens","tissue: benign thyriod nodule","fraction: circulating exosomes","plasma exosomal RNA was isolated from petient with benign thyriod nodule, metiastatic thyroid cancer, non-metastatic thyroid cancer, and healty individuals.","total RNA","The miRNAs were extracted from plasma-isolated exosomes using the miRNeasy Micro Kit per the manufacturer’s protocol","Small RNA libraries were constructed as instructed by the NEBNext Multiplex Small RNA Library Prep Set for Illumina (NEB, Ipswich, MA, USA) with minor modifications. Ten ng of small RNA were used as the starting material. After sequential ligation of the Multiplex 3’ SR Adaptor, hybridization of the reverse transcription primer, and ligation of the Multiplex 5’ SR Adaptor, the RNA-Adaptor complex was reversed transcribed into cDNA. Then the small RNA libraries were amplified and the Illumina compatible Index Primers were incorporated with 10 cycles of PCR amplification. The amplified libraries were resolved on a native 5% acrylamide gel (Bio-rad, Hercules, CA). DNA fragments corresponding to 140 - 160 bp (the size comprising the miRNA inserts plus the 3’ and 5’ adaptors) were recovered in 12 μL of Elution Buffer (QIAGEN) and determined with High Sensitivity DNA Chip on Agilent 2100 bioanalyzer. Absolute quantities of each indexed library were determined by real time qPCR using KAPA Library Quantification Kit according to the manufacture’s protocol.","9606","miRNA","The clustering of the index-coded samples was performed on a cBot Cluster Generation System using TruSeq SR Cluster Kit v3-cBot-HS (Illumia).","After cluster generation, the libraries were sequenced and 50bp single-end reads were generated.","The raw data (raw reads) extracted from FASTQ files were firstly processed through perl and python scripts. In this step, clean data(clean reads) were generated by removing reads containing ploy-N, with 5’ adapter contaminants, without 3’ adapter or the insert tag, containing ploy A or T or G or C and low quality reads from raw data.","Then the clean data were aligned against human miRNA sequences from miRBase (Release 20) and NCBI human genome reference sequences (Release 103) using Bowtie (version 0.12.8) .","miRNA profiling was normalized using read counts of a specific miRNA per million(TPM) mappable miRNA sequences. To find novel miRNAs, the raw data was independently processed by combined use of miRDeep 2 and miREvo. Predicted miRNAs with scores ≥ 2 were considered significant.","GPL11154","Xiaoyi,,Huang","harbinner@hotmail.com","86-451-86298745","Harbin Medical University Cancer Hospital","Haping Road 150","Harbin","Heilongjiang","150081","China","0","Illumina HiSeq 2000","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11539272","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5771421","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3741nnn/GSM3741567/suppl/GSM3741567_X3_clean.fa.gz","circulating exosomes","benign thyriod nodule"
"GSM3741568","X4: benign thyriod nodule","GSM3741568","Public on May 01 2019","Apr 30 2019","May 15 2019","SRA","1","plasma","Homo sapiens","tissue: benign thyriod nodule","fraction: circulating exosomes","plasma exosomal RNA was isolated from petient with benign thyriod nodule, metiastatic thyroid cancer, non-metastatic thyroid cancer, and healty individuals.","total RNA","The miRNAs were extracted from plasma-isolated exosomes using the miRNeasy Micro Kit per the manufacturer’s protocol","Small RNA libraries were constructed as instructed by the NEBNext Multiplex Small RNA Library Prep Set for Illumina (NEB, Ipswich, MA, USA) with minor modifications. Ten ng of small RNA were used as the starting material. After sequential ligation of the Multiplex 3’ SR Adaptor, hybridization of the reverse transcription primer, and ligation of the Multiplex 5’ SR Adaptor, the RNA-Adaptor complex was reversed transcribed into cDNA. Then the small RNA libraries were amplified and the Illumina compatible Index Primers were incorporated with 10 cycles of PCR amplification. The amplified libraries were resolved on a native 5% acrylamide gel (Bio-rad, Hercules, CA). DNA fragments corresponding to 140 - 160 bp (the size comprising the miRNA inserts plus the 3’ and 5’ adaptors) were recovered in 12 μL of Elution Buffer (QIAGEN) and determined with High Sensitivity DNA Chip on Agilent 2100 bioanalyzer. Absolute quantities of each indexed library were determined by real time qPCR using KAPA Library Quantification Kit according to the manufacture’s protocol.","9606","miRNA","The clustering of the index-coded samples was performed on a cBot Cluster Generation System using TruSeq SR Cluster Kit v3-cBot-HS (Illumia).","After cluster generation, the libraries were sequenced and 50bp single-end reads were generated.","The raw data (raw reads) extracted from FASTQ files were firstly processed through perl and python scripts. In this step, clean data(clean reads) were generated by removing reads containing ploy-N, with 5’ adapter contaminants, without 3’ adapter or the insert tag, containing ploy A or T or G or C and low quality reads from raw data.","Then the clean data were aligned against human miRNA sequences from miRBase (Release 20) and NCBI human genome reference sequences (Release 103) using Bowtie (version 0.12.8) .","miRNA profiling was normalized using read counts of a specific miRNA per million(TPM) mappable miRNA sequences. To find novel miRNAs, the raw data was independently processed by combined use of miRDeep 2 and miREvo. Predicted miRNAs with scores ≥ 2 were considered significant.","GPL11154","Xiaoyi,,Huang","harbinner@hotmail.com","86-451-86298745","Harbin Medical University Cancer Hospital","Haping Road 150","Harbin","Heilongjiang","150081","China","0","Illumina HiSeq 2000","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11539271","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5771422","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3741nnn/GSM3741568/suppl/GSM3741568_X4_clean.fa.gz","circulating exosomes","benign thyriod nodule"
"GSM3741569","X5: benign thyriod nodule","GSM3741569","Public on May 01 2019","Apr 30 2019","May 15 2019","SRA","1","plasma","Homo sapiens","tissue: benign thyriod nodule","fraction: circulating exosomes","plasma exosomal RNA was isolated from petient with benign thyriod nodule, metiastatic thyroid cancer, non-metastatic thyroid cancer, and healty individuals.","total RNA","The miRNAs were extracted from plasma-isolated exosomes using the miRNeasy Micro Kit per the manufacturer’s protocol","Small RNA libraries were constructed as instructed by the NEBNext Multiplex Small RNA Library Prep Set for Illumina (NEB, Ipswich, MA, USA) with minor modifications. Ten ng of small RNA were used as the starting material. After sequential ligation of the Multiplex 3’ SR Adaptor, hybridization of the reverse transcription primer, and ligation of the Multiplex 5’ SR Adaptor, the RNA-Adaptor complex was reversed transcribed into cDNA. Then the small RNA libraries were amplified and the Illumina compatible Index Primers were incorporated with 10 cycles of PCR amplification. The amplified libraries were resolved on a native 5% acrylamide gel (Bio-rad, Hercules, CA). DNA fragments corresponding to 140 - 160 bp (the size comprising the miRNA inserts plus the 3’ and 5’ adaptors) were recovered in 12 μL of Elution Buffer (QIAGEN) and determined with High Sensitivity DNA Chip on Agilent 2100 bioanalyzer. Absolute quantities of each indexed library were determined by real time qPCR using KAPA Library Quantification Kit according to the manufacture’s protocol.","9606","miRNA","The clustering of the index-coded samples was performed on a cBot Cluster Generation System using TruSeq SR Cluster Kit v3-cBot-HS (Illumia).","After cluster generation, the libraries were sequenced and 50bp single-end reads were generated.","The raw data (raw reads) extracted from FASTQ files were firstly processed through perl and python scripts. In this step, clean data(clean reads) were generated by removing reads containing ploy-N, with 5’ adapter contaminants, without 3’ adapter or the insert tag, containing ploy A or T or G or C and low quality reads from raw data.","Then the clean data were aligned against human miRNA sequences from miRBase (Release 20) and NCBI human genome reference sequences (Release 103) using Bowtie (version 0.12.8) .","miRNA profiling was normalized using read counts of a specific miRNA per million(TPM) mappable miRNA sequences. To find novel miRNAs, the raw data was independently processed by combined use of miRDeep 2 and miREvo. Predicted miRNAs with scores ≥ 2 were considered significant.","GPL11154","Xiaoyi,,Huang","harbinner@hotmail.com","86-451-86298745","Harbin Medical University Cancer Hospital","Haping Road 150","Harbin","Heilongjiang","150081","China","0","Illumina HiSeq 2000","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11539270","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5771423","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3741nnn/GSM3741569/suppl/GSM3741569_X5_clean.fa.gz","circulating exosomes","benign thyriod nodule"
"GSM3741570","X6: benign thyriod nodule","GSM3741570","Public on May 01 2019","Apr 30 2019","May 15 2019","SRA","1","plasma","Homo sapiens","tissue: benign thyriod nodule","fraction: circulating exosomes","plasma exosomal RNA was isolated from petient with benign thyriod nodule, metiastatic thyroid cancer, non-metastatic thyroid cancer, and healty individuals.","total RNA","The miRNAs were extracted from plasma-isolated exosomes using the miRNeasy Micro Kit per the manufacturer’s protocol","Small RNA libraries were constructed as instructed by the NEBNext Multiplex Small RNA Library Prep Set for Illumina (NEB, Ipswich, MA, USA) with minor modifications. Ten ng of small RNA were used as the starting material. After sequential ligation of the Multiplex 3’ SR Adaptor, hybridization of the reverse transcription primer, and ligation of the Multiplex 5’ SR Adaptor, the RNA-Adaptor complex was reversed transcribed into cDNA. Then the small RNA libraries were amplified and the Illumina compatible Index Primers were incorporated with 10 cycles of PCR amplification. The amplified libraries were resolved on a native 5% acrylamide gel (Bio-rad, Hercules, CA). DNA fragments corresponding to 140 - 160 bp (the size comprising the miRNA inserts plus the 3’ and 5’ adaptors) were recovered in 12 μL of Elution Buffer (QIAGEN) and determined with High Sensitivity DNA Chip on Agilent 2100 bioanalyzer. Absolute quantities of each indexed library were determined by real time qPCR using KAPA Library Quantification Kit according to the manufacture’s protocol.","9606","miRNA","The clustering of the index-coded samples was performed on a cBot Cluster Generation System using TruSeq SR Cluster Kit v3-cBot-HS (Illumia).","After cluster generation, the libraries were sequenced and 50bp single-end reads were generated.","The raw data (raw reads) extracted from FASTQ files were firstly processed through perl and python scripts. In this step, clean data(clean reads) were generated by removing reads containing ploy-N, with 5’ adapter contaminants, without 3’ adapter or the insert tag, containing ploy A or T or G or C and low quality reads from raw data.","Then the clean data were aligned against human miRNA sequences from miRBase (Release 20) and NCBI human genome reference sequences (Release 103) using Bowtie (version 0.12.8) .","miRNA profiling was normalized using read counts of a specific miRNA per million(TPM) mappable miRNA sequences. To find novel miRNAs, the raw data was independently processed by combined use of miRDeep 2 and miREvo. Predicted miRNAs with scores ≥ 2 were considered significant.","GPL11154","Xiaoyi,,Huang","harbinner@hotmail.com","86-451-86298745","Harbin Medical University Cancer Hospital","Haping Road 150","Harbin","Heilongjiang","150081","China","0","Illumina HiSeq 2000","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11539269","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5771424","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3741nnn/GSM3741570/suppl/GSM3741570_X6_clean.fa.gz","circulating exosomes","benign thyriod nodule"
"GSM3741571","X7: benign thyriod nodule","GSM3741571","Public on May 01 2019","Apr 30 2019","May 15 2019","SRA","1","plasma","Homo sapiens","tissue: benign thyriod nodule","fraction: circulating exosomes","plasma exosomal RNA was isolated from petient with benign thyriod nodule, metiastatic thyroid cancer, non-metastatic thyroid cancer, and healty individuals.","total RNA","The miRNAs were extracted from plasma-isolated exosomes using the miRNeasy Micro Kit per the manufacturer’s protocol","Small RNA libraries were constructed as instructed by the NEBNext Multiplex Small RNA Library Prep Set for Illumina (NEB, Ipswich, MA, USA) with minor modifications. Ten ng of small RNA were used as the starting material. After sequential ligation of the Multiplex 3’ SR Adaptor, hybridization of the reverse transcription primer, and ligation of the Multiplex 5’ SR Adaptor, the RNA-Adaptor complex was reversed transcribed into cDNA. Then the small RNA libraries were amplified and the Illumina compatible Index Primers were incorporated with 10 cycles of PCR amplification. The amplified libraries were resolved on a native 5% acrylamide gel (Bio-rad, Hercules, CA). DNA fragments corresponding to 140 - 160 bp (the size comprising the miRNA inserts plus the 3’ and 5’ adaptors) were recovered in 12 μL of Elution Buffer (QIAGEN) and determined with High Sensitivity DNA Chip on Agilent 2100 bioanalyzer. Absolute quantities of each indexed library were determined by real time qPCR using KAPA Library Quantification Kit according to the manufacture’s protocol.","9606","miRNA","The clustering of the index-coded samples was performed on a cBot Cluster Generation System using TruSeq SR Cluster Kit v3-cBot-HS (Illumia).","After cluster generation, the libraries were sequenced and 50bp single-end reads were generated.","The raw data (raw reads) extracted from FASTQ files were firstly processed through perl and python scripts. In this step, clean data(clean reads) were generated by removing reads containing ploy-N, with 5’ adapter contaminants, without 3’ adapter or the insert tag, containing ploy A or T or G or C and low quality reads from raw data.","Then the clean data were aligned against human miRNA sequences from miRBase (Release 20) and NCBI human genome reference sequences (Release 103) using Bowtie (version 0.12.8) .","miRNA profiling was normalized using read counts of a specific miRNA per million(TPM) mappable miRNA sequences. To find novel miRNAs, the raw data was independently processed by combined use of miRDeep 2 and miREvo. Predicted miRNAs with scores ≥ 2 were considered significant.","GPL11154","Xiaoyi,,Huang","harbinner@hotmail.com","86-451-86298745","Harbin Medical University Cancer Hospital","Haping Road 150","Harbin","Heilongjiang","150081","China","0","Illumina HiSeq 2000","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11539268","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5771425","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3741nnn/GSM3741571/suppl/GSM3741571_X7_clean.fa.gz","circulating exosomes","benign thyriod nodule"
"GSM3741572","X8: benign thyriod nodule","GSM3741572","Public on May 01 2019","Apr 30 2019","May 15 2019","SRA","1","plasma","Homo sapiens","tissue: benign thyriod nodule","fraction: circulating exosomes","plasma exosomal RNA was isolated from petient with benign thyriod nodule, metiastatic thyroid cancer, non-metastatic thyroid cancer, and healty individuals.","total RNA","The miRNAs were extracted from plasma-isolated exosomes using the miRNeasy Micro Kit per the manufacturer’s protocol","Small RNA libraries were constructed as instructed by the NEBNext Multiplex Small RNA Library Prep Set for Illumina (NEB, Ipswich, MA, USA) with minor modifications. Ten ng of small RNA were used as the starting material. After sequential ligation of the Multiplex 3’ SR Adaptor, hybridization of the reverse transcription primer, and ligation of the Multiplex 5’ SR Adaptor, the RNA-Adaptor complex was reversed transcribed into cDNA. Then the small RNA libraries were amplified and the Illumina compatible Index Primers were incorporated with 10 cycles of PCR amplification. The amplified libraries were resolved on a native 5% acrylamide gel (Bio-rad, Hercules, CA). DNA fragments corresponding to 140 - 160 bp (the size comprising the miRNA inserts plus the 3’ and 5’ adaptors) were recovered in 12 μL of Elution Buffer (QIAGEN) and determined with High Sensitivity DNA Chip on Agilent 2100 bioanalyzer. Absolute quantities of each indexed library were determined by real time qPCR using KAPA Library Quantification Kit according to the manufacture’s protocol.","9606","miRNA","The clustering of the index-coded samples was performed on a cBot Cluster Generation System using TruSeq SR Cluster Kit v3-cBot-HS (Illumia).","After cluster generation, the libraries were sequenced and 50bp single-end reads were generated.","The raw data (raw reads) extracted from FASTQ files were firstly processed through perl and python scripts. In this step, clean data(clean reads) were generated by removing reads containing ploy-N, with 5’ adapter contaminants, without 3’ adapter or the insert tag, containing ploy A or T or G or C and low quality reads from raw data.","Then the clean data were aligned against human miRNA sequences from miRBase (Release 20) and NCBI human genome reference sequences (Release 103) using Bowtie (version 0.12.8) .","miRNA profiling was normalized using read counts of a specific miRNA per million(TPM) mappable miRNA sequences. To find novel miRNAs, the raw data was independently processed by combined use of miRDeep 2 and miREvo. Predicted miRNAs with scores ≥ 2 were considered significant.","GPL11154","Xiaoyi,,Huang","harbinner@hotmail.com","86-451-86298745","Harbin Medical University Cancer Hospital","Haping Road 150","Harbin","Heilongjiang","150081","China","0","Illumina HiSeq 2000","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11539267","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5771426","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3741nnn/GSM3741572/suppl/GSM3741572_X8_clean.fa.gz","circulating exosomes","benign thyriod nodule"
"GSM3741573","Y1: thyroid cancer without metastasis","GSM3741573","Public on May 01 2019","Apr 30 2019","May 15 2019","SRA","1","plasma","Homo sapiens","tissue: thyroid cancer without metastasis","fraction: circulating exosomes","plasma exosomal RNA was isolated from petient with benign thyriod nodule, metiastatic thyroid cancer, non-metastatic thyroid cancer, and healty individuals.","total RNA","The miRNAs were extracted from plasma-isolated exosomes using the miRNeasy Micro Kit per the manufacturer’s protocol","Small RNA libraries were constructed as instructed by the NEBNext Multiplex Small RNA Library Prep Set for Illumina (NEB, Ipswich, MA, USA) with minor modifications. Ten ng of small RNA were used as the starting material. After sequential ligation of the Multiplex 3’ SR Adaptor, hybridization of the reverse transcription primer, and ligation of the Multiplex 5’ SR Adaptor, the RNA-Adaptor complex was reversed transcribed into cDNA. Then the small RNA libraries were amplified and the Illumina compatible Index Primers were incorporated with 10 cycles of PCR amplification. The amplified libraries were resolved on a native 5% acrylamide gel (Bio-rad, Hercules, CA). DNA fragments corresponding to 140 - 160 bp (the size comprising the miRNA inserts plus the 3’ and 5’ adaptors) were recovered in 12 μL of Elution Buffer (QIAGEN) and determined with High Sensitivity DNA Chip on Agilent 2100 bioanalyzer. Absolute quantities of each indexed library were determined by real time qPCR using KAPA Library Quantification Kit according to the manufacture’s protocol.","9606","miRNA","The clustering of the index-coded samples was performed on a cBot Cluster Generation System using TruSeq SR Cluster Kit v3-cBot-HS (Illumia).","After cluster generation, the libraries were sequenced and 50bp single-end reads were generated.","The raw data (raw reads) extracted from FASTQ files were firstly processed through perl and python scripts. In this step, clean data(clean reads) were generated by removing reads containing ploy-N, with 5’ adapter contaminants, without 3’ adapter or the insert tag, containing ploy A or T or G or C and low quality reads from raw data.","Then the clean data were aligned against human miRNA sequences from miRBase (Release 20) and NCBI human genome reference sequences (Release 103) using Bowtie (version 0.12.8) .","miRNA profiling was normalized using read counts of a specific miRNA per million(TPM) mappable miRNA sequences. To find novel miRNAs, the raw data was independently processed by combined use of miRDeep 2 and miREvo. Predicted miRNAs with scores ≥ 2 were considered significant.","GPL11154","Xiaoyi,,Huang","harbinner@hotmail.com","86-451-86298745","Harbin Medical University Cancer Hospital","Haping Road 150","Harbin","Heilongjiang","150081","China","0","Illumina HiSeq 2000","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11539266","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5771427","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3741nnn/GSM3741573/suppl/GSM3741573_Y1_clean.fa.gz","circulating exosomes","thyroid cancer without metastasis"
"GSM3741574","Y2: thyroid cancer without metastasis","GSM3741574","Public on May 01 2019","Apr 30 2019","May 15 2019","SRA","1","plasma","Homo sapiens","tissue: thyroid cancer without metastasis","fraction: circulating exosomes","plasma exosomal RNA was isolated from petient with benign thyriod nodule, metiastatic thyroid cancer, non-metastatic thyroid cancer, and healty individuals.","total RNA","The miRNAs were extracted from plasma-isolated exosomes using the miRNeasy Micro Kit per the manufacturer’s protocol","Small RNA libraries were constructed as instructed by the NEBNext Multiplex Small RNA Library Prep Set for Illumina (NEB, Ipswich, MA, USA) with minor modifications. Ten ng of small RNA were used as the starting material. After sequential ligation of the Multiplex 3’ SR Adaptor, hybridization of the reverse transcription primer, and ligation of the Multiplex 5’ SR Adaptor, the RNA-Adaptor complex was reversed transcribed into cDNA. Then the small RNA libraries were amplified and the Illumina compatible Index Primers were incorporated with 10 cycles of PCR amplification. The amplified libraries were resolved on a native 5% acrylamide gel (Bio-rad, Hercules, CA). DNA fragments corresponding to 140 - 160 bp (the size comprising the miRNA inserts plus the 3’ and 5’ adaptors) were recovered in 12 μL of Elution Buffer (QIAGEN) and determined with High Sensitivity DNA Chip on Agilent 2100 bioanalyzer. Absolute quantities of each indexed library were determined by real time qPCR using KAPA Library Quantification Kit according to the manufacture’s protocol.","9606","miRNA","The clustering of the index-coded samples was performed on a cBot Cluster Generation System using TruSeq SR Cluster Kit v3-cBot-HS (Illumia).","After cluster generation, the libraries were sequenced and 50bp single-end reads were generated.","The raw data (raw reads) extracted from FASTQ files were firstly processed through perl and python scripts. In this step, clean data(clean reads) were generated by removing reads containing ploy-N, with 5’ adapter contaminants, without 3’ adapter or the insert tag, containing ploy A or T or G or C and low quality reads from raw data.","Then the clean data were aligned against human miRNA sequences from miRBase (Release 20) and NCBI human genome reference sequences (Release 103) using Bowtie (version 0.12.8) .","miRNA profiling was normalized using read counts of a specific miRNA per million(TPM) mappable miRNA sequences. To find novel miRNAs, the raw data was independently processed by combined use of miRDeep 2 and miREvo. Predicted miRNAs with scores ≥ 2 were considered significant.","GPL11154","Xiaoyi,,Huang","harbinner@hotmail.com","86-451-86298745","Harbin Medical University Cancer Hospital","Haping Road 150","Harbin","Heilongjiang","150081","China","0","Illumina HiSeq 2000","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11539265","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5771428","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3741nnn/GSM3741574/suppl/GSM3741574_Y2_clean.fa.gz","circulating exosomes","thyroid cancer without metastasis"
"GSM3741575","Y3: thyroid cancer without metastasis","GSM3741575","Public on May 01 2019","Apr 30 2019","May 15 2019","SRA","1","plasma","Homo sapiens","tissue: thyroid cancer without metastasis","fraction: circulating exosomes","plasma exosomal RNA was isolated from petient with benign thyriod nodule, metiastatic thyroid cancer, non-metastatic thyroid cancer, and healty individuals.","total RNA","The miRNAs were extracted from plasma-isolated exosomes using the miRNeasy Micro Kit per the manufacturer’s protocol","Small RNA libraries were constructed as instructed by the NEBNext Multiplex Small RNA Library Prep Set for Illumina (NEB, Ipswich, MA, USA) with minor modifications. Ten ng of small RNA were used as the starting material. After sequential ligation of the Multiplex 3’ SR Adaptor, hybridization of the reverse transcription primer, and ligation of the Multiplex 5’ SR Adaptor, the RNA-Adaptor complex was reversed transcribed into cDNA. Then the small RNA libraries were amplified and the Illumina compatible Index Primers were incorporated with 10 cycles of PCR amplification. The amplified libraries were resolved on a native 5% acrylamide gel (Bio-rad, Hercules, CA). DNA fragments corresponding to 140 - 160 bp (the size comprising the miRNA inserts plus the 3’ and 5’ adaptors) were recovered in 12 μL of Elution Buffer (QIAGEN) and determined with High Sensitivity DNA Chip on Agilent 2100 bioanalyzer. Absolute quantities of each indexed library were determined by real time qPCR using KAPA Library Quantification Kit according to the manufacture’s protocol.","9606","miRNA","The clustering of the index-coded samples was performed on a cBot Cluster Generation System using TruSeq SR Cluster Kit v3-cBot-HS (Illumia).","After cluster generation, the libraries were sequenced and 50bp single-end reads were generated.","The raw data (raw reads) extracted from FASTQ files were firstly processed through perl and python scripts. In this step, clean data(clean reads) were generated by removing reads containing ploy-N, with 5’ adapter contaminants, without 3’ adapter or the insert tag, containing ploy A or T or G or C and low quality reads from raw data.","Then the clean data were aligned against human miRNA sequences from miRBase (Release 20) and NCBI human genome reference sequences (Release 103) using Bowtie (version 0.12.8) .","miRNA profiling was normalized using read counts of a specific miRNA per million(TPM) mappable miRNA sequences. To find novel miRNAs, the raw data was independently processed by combined use of miRDeep 2 and miREvo. Predicted miRNAs with scores ≥ 2 were considered significant.","GPL11154","Xiaoyi,,Huang","harbinner@hotmail.com","86-451-86298745","Harbin Medical University Cancer Hospital","Haping Road 150","Harbin","Heilongjiang","150081","China","0","Illumina HiSeq 2000","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11539264","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5771429","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3741nnn/GSM3741575/suppl/GSM3741575_Y3_clean.fa.gz","circulating exosomes","thyroid cancer without metastasis"
"GSM3741576","Y4: thyroid cancer without metastasis","GSM3741576","Public on May 01 2019","Apr 30 2019","May 15 2019","SRA","1","plasma","Homo sapiens","tissue: thyroid cancer without metastasis","fraction: circulating exosomes","plasma exosomal RNA was isolated from petient with benign thyriod nodule, metiastatic thyroid cancer, non-metastatic thyroid cancer, and healty individuals.","total RNA","The miRNAs were extracted from plasma-isolated exosomes using the miRNeasy Micro Kit per the manufacturer’s protocol","Small RNA libraries were constructed as instructed by the NEBNext Multiplex Small RNA Library Prep Set for Illumina (NEB, Ipswich, MA, USA) with minor modifications. Ten ng of small RNA were used as the starting material. After sequential ligation of the Multiplex 3’ SR Adaptor, hybridization of the reverse transcription primer, and ligation of the Multiplex 5’ SR Adaptor, the RNA-Adaptor complex was reversed transcribed into cDNA. Then the small RNA libraries were amplified and the Illumina compatible Index Primers were incorporated with 10 cycles of PCR amplification. The amplified libraries were resolved on a native 5% acrylamide gel (Bio-rad, Hercules, CA). DNA fragments corresponding to 140 - 160 bp (the size comprising the miRNA inserts plus the 3’ and 5’ adaptors) were recovered in 12 μL of Elution Buffer (QIAGEN) and determined with High Sensitivity DNA Chip on Agilent 2100 bioanalyzer. Absolute quantities of each indexed library were determined by real time qPCR using KAPA Library Quantification Kit according to the manufacture’s protocol.","9606","miRNA","The clustering of the index-coded samples was performed on a cBot Cluster Generation System using TruSeq SR Cluster Kit v3-cBot-HS (Illumia).","After cluster generation, the libraries were sequenced and 50bp single-end reads were generated.","The raw data (raw reads) extracted from FASTQ files were firstly processed through perl and python scripts. In this step, clean data(clean reads) were generated by removing reads containing ploy-N, with 5’ adapter contaminants, without 3’ adapter or the insert tag, containing ploy A or T or G or C and low quality reads from raw data.","Then the clean data were aligned against human miRNA sequences from miRBase (Release 20) and NCBI human genome reference sequences (Release 103) using Bowtie (version 0.12.8) .","miRNA profiling was normalized using read counts of a specific miRNA per million(TPM) mappable miRNA sequences. To find novel miRNAs, the raw data was independently processed by combined use of miRDeep 2 and miREvo. Predicted miRNAs with scores ≥ 2 were considered significant.","GPL11154","Xiaoyi,,Huang","harbinner@hotmail.com","86-451-86298745","Harbin Medical University Cancer Hospital","Haping Road 150","Harbin","Heilongjiang","150081","China","0","Illumina HiSeq 2000","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11539263","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5771430","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3741nnn/GSM3741576/suppl/GSM3741576_Y4_clean.fa.gz","circulating exosomes","thyroid cancer without metastasis"
"GSM3741577","Y5: thyroid cancer without metastasis","GSM3741577","Public on May 01 2019","Apr 30 2019","May 15 2019","SRA","1","plasma","Homo sapiens","tissue: thyroid cancer without metastasis","fraction: circulating exosomes","plasma exosomal RNA was isolated from petient with benign thyriod nodule, metiastatic thyroid cancer, non-metastatic thyroid cancer, and healty individuals.","total RNA","The miRNAs were extracted from plasma-isolated exosomes using the miRNeasy Micro Kit per the manufacturer’s protocol","Small RNA libraries were constructed as instructed by the NEBNext Multiplex Small RNA Library Prep Set for Illumina (NEB, Ipswich, MA, USA) with minor modifications. Ten ng of small RNA were used as the starting material. After sequential ligation of the Multiplex 3’ SR Adaptor, hybridization of the reverse transcription primer, and ligation of the Multiplex 5’ SR Adaptor, the RNA-Adaptor complex was reversed transcribed into cDNA. Then the small RNA libraries were amplified and the Illumina compatible Index Primers were incorporated with 10 cycles of PCR amplification. The amplified libraries were resolved on a native 5% acrylamide gel (Bio-rad, Hercules, CA). DNA fragments corresponding to 140 - 160 bp (the size comprising the miRNA inserts plus the 3’ and 5’ adaptors) were recovered in 12 μL of Elution Buffer (QIAGEN) and determined with High Sensitivity DNA Chip on Agilent 2100 bioanalyzer. Absolute quantities of each indexed library were determined by real time qPCR using KAPA Library Quantification Kit according to the manufacture’s protocol.","9606","miRNA","The clustering of the index-coded samples was performed on a cBot Cluster Generation System using TruSeq SR Cluster Kit v3-cBot-HS (Illumia).","After cluster generation, the libraries were sequenced and 50bp single-end reads were generated.","The raw data (raw reads) extracted from FASTQ files were firstly processed through perl and python scripts. In this step, clean data(clean reads) were generated by removing reads containing ploy-N, with 5’ adapter contaminants, without 3’ adapter or the insert tag, containing ploy A or T or G or C and low quality reads from raw data.","Then the clean data were aligned against human miRNA sequences from miRBase (Release 20) and NCBI human genome reference sequences (Release 103) using Bowtie (version 0.12.8) .","miRNA profiling was normalized using read counts of a specific miRNA per million(TPM) mappable miRNA sequences. To find novel miRNAs, the raw data was independently processed by combined use of miRDeep 2 and miREvo. Predicted miRNAs with scores ≥ 2 were considered significant.","GPL11154","Xiaoyi,,Huang","harbinner@hotmail.com","86-451-86298745","Harbin Medical University Cancer Hospital","Haping Road 150","Harbin","Heilongjiang","150081","China","0","Illumina HiSeq 2000","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11539280","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5771431","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3741nnn/GSM3741577/suppl/GSM3741577_Y5_clean.fa.gz","circulating exosomes","thyroid cancer without metastasis"
"GSM3741578","Y6: thyroid cancer without metastasis","GSM3741578","Public on May 01 2019","Apr 30 2019","May 15 2019","SRA","1","plasma","Homo sapiens","tissue: thyroid cancer without metastasis","fraction: circulating exosomes","plasma exosomal RNA was isolated from petient with benign thyriod nodule, metiastatic thyroid cancer, non-metastatic thyroid cancer, and healty individuals.","total RNA","The miRNAs were extracted from plasma-isolated exosomes using the miRNeasy Micro Kit per the manufacturer’s protocol","Small RNA libraries were constructed as instructed by the NEBNext Multiplex Small RNA Library Prep Set for Illumina (NEB, Ipswich, MA, USA) with minor modifications. Ten ng of small RNA were used as the starting material. After sequential ligation of the Multiplex 3’ SR Adaptor, hybridization of the reverse transcription primer, and ligation of the Multiplex 5’ SR Adaptor, the RNA-Adaptor complex was reversed transcribed into cDNA. Then the small RNA libraries were amplified and the Illumina compatible Index Primers were incorporated with 10 cycles of PCR amplification. The amplified libraries were resolved on a native 5% acrylamide gel (Bio-rad, Hercules, CA). DNA fragments corresponding to 140 - 160 bp (the size comprising the miRNA inserts plus the 3’ and 5’ adaptors) were recovered in 12 μL of Elution Buffer (QIAGEN) and determined with High Sensitivity DNA Chip on Agilent 2100 bioanalyzer. Absolute quantities of each indexed library were determined by real time qPCR using KAPA Library Quantification Kit according to the manufacture’s protocol.","9606","miRNA","The clustering of the index-coded samples was performed on a cBot Cluster Generation System using TruSeq SR Cluster Kit v3-cBot-HS (Illumia).","After cluster generation, the libraries were sequenced and 50bp single-end reads were generated.","The raw data (raw reads) extracted from FASTQ files were firstly processed through perl and python scripts. In this step, clean data(clean reads) were generated by removing reads containing ploy-N, with 5’ adapter contaminants, without 3’ adapter or the insert tag, containing ploy A or T or G or C and low quality reads from raw data.","Then the clean data were aligned against human miRNA sequences from miRBase (Release 20) and NCBI human genome reference sequences (Release 103) using Bowtie (version 0.12.8) .","miRNA profiling was normalized using read counts of a specific miRNA per million(TPM) mappable miRNA sequences. To find novel miRNAs, the raw data was independently processed by combined use of miRDeep 2 and miREvo. Predicted miRNAs with scores ≥ 2 were considered significant.","GPL11154","Xiaoyi,,Huang","harbinner@hotmail.com","86-451-86298745","Harbin Medical University Cancer Hospital","Haping Road 150","Harbin","Heilongjiang","150081","China","0","Illumina HiSeq 2000","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11539279","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5771432","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3741nnn/GSM3741578/suppl/GSM3741578_Y6_clean.fa.gz","circulating exosomes","thyroid cancer without metastasis"
"GSM3741579","Y7: thyroid cancer without metastasis","GSM3741579","Public on May 01 2019","Apr 30 2019","May 15 2019","SRA","1","plasma","Homo sapiens","tissue: thyroid cancer without metastasis","fraction: circulating exosomes","plasma exosomal RNA was isolated from petient with benign thyriod nodule, metiastatic thyroid cancer, non-metastatic thyroid cancer, and healty individuals.","total RNA","The miRNAs were extracted from plasma-isolated exosomes using the miRNeasy Micro Kit per the manufacturer’s protocol","Small RNA libraries were constructed as instructed by the NEBNext Multiplex Small RNA Library Prep Set for Illumina (NEB, Ipswich, MA, USA) with minor modifications. Ten ng of small RNA were used as the starting material. After sequential ligation of the Multiplex 3’ SR Adaptor, hybridization of the reverse transcription primer, and ligation of the Multiplex 5’ SR Adaptor, the RNA-Adaptor complex was reversed transcribed into cDNA. Then the small RNA libraries were amplified and the Illumina compatible Index Primers were incorporated with 10 cycles of PCR amplification. The amplified libraries were resolved on a native 5% acrylamide gel (Bio-rad, Hercules, CA). DNA fragments corresponding to 140 - 160 bp (the size comprising the miRNA inserts plus the 3’ and 5’ adaptors) were recovered in 12 μL of Elution Buffer (QIAGEN) and determined with High Sensitivity DNA Chip on Agilent 2100 bioanalyzer. Absolute quantities of each indexed library were determined by real time qPCR using KAPA Library Quantification Kit according to the manufacture’s protocol.","9606","miRNA","The clustering of the index-coded samples was performed on a cBot Cluster Generation System using TruSeq SR Cluster Kit v3-cBot-HS (Illumia).","After cluster generation, the libraries were sequenced and 50bp single-end reads were generated.","The raw data (raw reads) extracted from FASTQ files were firstly processed through perl and python scripts. In this step, clean data(clean reads) were generated by removing reads containing ploy-N, with 5’ adapter contaminants, without 3’ adapter or the insert tag, containing ploy A or T or G or C and low quality reads from raw data.","Then the clean data were aligned against human miRNA sequences from miRBase (Release 20) and NCBI human genome reference sequences (Release 103) using Bowtie (version 0.12.8) .","miRNA profiling was normalized using read counts of a specific miRNA per million(TPM) mappable miRNA sequences. To find novel miRNAs, the raw data was independently processed by combined use of miRDeep 2 and miREvo. Predicted miRNAs with scores ≥ 2 were considered significant.","GPL11154","Xiaoyi,,Huang","harbinner@hotmail.com","86-451-86298745","Harbin Medical University Cancer Hospital","Haping Road 150","Harbin","Heilongjiang","150081","China","0","Illumina HiSeq 2000","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11539278","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5771433","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3741nnn/GSM3741579/suppl/GSM3741579_Y7_clean.fa.gz","circulating exosomes","thyroid cancer without metastasis"
"GSM3741580","Y8: thyroid cancer without metastasis","GSM3741580","Public on May 01 2019","Apr 30 2019","May 15 2019","SRA","1","plasma","Homo sapiens","tissue: thyroid cancer without metastasis","fraction: circulating exosomes","plasma exosomal RNA was isolated from petient with benign thyriod nodule, metiastatic thyroid cancer, non-metastatic thyroid cancer, and healty individuals.","total RNA","The miRNAs were extracted from plasma-isolated exosomes using the miRNeasy Micro Kit per the manufacturer’s protocol","Small RNA libraries were constructed as instructed by the NEBNext Multiplex Small RNA Library Prep Set for Illumina (NEB, Ipswich, MA, USA) with minor modifications. Ten ng of small RNA were used as the starting material. After sequential ligation of the Multiplex 3’ SR Adaptor, hybridization of the reverse transcription primer, and ligation of the Multiplex 5’ SR Adaptor, the RNA-Adaptor complex was reversed transcribed into cDNA. Then the small RNA libraries were amplified and the Illumina compatible Index Primers were incorporated with 10 cycles of PCR amplification. The amplified libraries were resolved on a native 5% acrylamide gel (Bio-rad, Hercules, CA). DNA fragments corresponding to 140 - 160 bp (the size comprising the miRNA inserts plus the 3’ and 5’ adaptors) were recovered in 12 μL of Elution Buffer (QIAGEN) and determined with High Sensitivity DNA Chip on Agilent 2100 bioanalyzer. Absolute quantities of each indexed library were determined by real time qPCR using KAPA Library Quantification Kit according to the manufacture’s protocol.","9606","miRNA","The clustering of the index-coded samples was performed on a cBot Cluster Generation System using TruSeq SR Cluster Kit v3-cBot-HS (Illumia).","After cluster generation, the libraries were sequenced and 50bp single-end reads were generated.","The raw data (raw reads) extracted from FASTQ files were firstly processed through perl and python scripts. In this step, clean data(clean reads) were generated by removing reads containing ploy-N, with 5’ adapter contaminants, without 3’ adapter or the insert tag, containing ploy A or T or G or C and low quality reads from raw data.","Then the clean data were aligned against human miRNA sequences from miRBase (Release 20) and NCBI human genome reference sequences (Release 103) using Bowtie (version 0.12.8) .","miRNA profiling was normalized using read counts of a specific miRNA per million(TPM) mappable miRNA sequences. To find novel miRNAs, the raw data was independently processed by combined use of miRDeep 2 and miREvo. Predicted miRNAs with scores ≥ 2 were considered significant.","GPL11154","Xiaoyi,,Huang","harbinner@hotmail.com","86-451-86298745","Harbin Medical University Cancer Hospital","Haping Road 150","Harbin","Heilongjiang","150081","China","0","Illumina HiSeq 2000","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11539277","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5771434","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3741nnn/GSM3741580/suppl/GSM3741580_Y8_clean.fa.gz","circulating exosomes","thyroid cancer without metastasis"
"GSM3741581","Z1: thyroid cancer with metastasis","GSM3741581","Public on May 01 2019","Apr 30 2019","May 15 2019","SRA","1","plasma","Homo sapiens","tissue: thyroid cancer with metastasis","fraction: circulating exosomes","plasma exosomal RNA was isolated from petient with benign thyriod nodule, metiastatic thyroid cancer, non-metastatic thyroid cancer, and healty individuals.","total RNA","The miRNAs were extracted from plasma-isolated exosomes using the miRNeasy Micro Kit per the manufacturer’s protocol","Small RNA libraries were constructed as instructed by the NEBNext Multiplex Small RNA Library Prep Set for Illumina (NEB, Ipswich, MA, USA) with minor modifications. Ten ng of small RNA were used as the starting material. After sequential ligation of the Multiplex 3’ SR Adaptor, hybridization of the reverse transcription primer, and ligation of the Multiplex 5’ SR Adaptor, the RNA-Adaptor complex was reversed transcribed into cDNA. Then the small RNA libraries were amplified and the Illumina compatible Index Primers were incorporated with 10 cycles of PCR amplification. The amplified libraries were resolved on a native 5% acrylamide gel (Bio-rad, Hercules, CA). DNA fragments corresponding to 140 - 160 bp (the size comprising the miRNA inserts plus the 3’ and 5’ adaptors) were recovered in 12 μL of Elution Buffer (QIAGEN) and determined with High Sensitivity DNA Chip on Agilent 2100 bioanalyzer. Absolute quantities of each indexed library were determined by real time qPCR using KAPA Library Quantification Kit according to the manufacture’s protocol.","9606","miRNA","The clustering of the index-coded samples was performed on a cBot Cluster Generation System using TruSeq SR Cluster Kit v3-cBot-HS (Illumia).","After cluster generation, the libraries were sequenced and 50bp single-end reads were generated.","The raw data (raw reads) extracted from FASTQ files were firstly processed through perl and python scripts. In this step, clean data(clean reads) were generated by removing reads containing ploy-N, with 5’ adapter contaminants, without 3’ adapter or the insert tag, containing ploy A or T or G or C and low quality reads from raw data.","Then the clean data were aligned against human miRNA sequences from miRBase (Release 20) and NCBI human genome reference sequences (Release 103) using Bowtie (version 0.12.8) .","miRNA profiling was normalized using read counts of a specific miRNA per million(TPM) mappable miRNA sequences. To find novel miRNAs, the raw data was independently processed by combined use of miRDeep 2 and miREvo. Predicted miRNAs with scores ≥ 2 were considered significant.","GPL11154","Xiaoyi,,Huang","harbinner@hotmail.com","86-451-86298745","Harbin Medical University Cancer Hospital","Haping Road 150","Harbin","Heilongjiang","150081","China","0","Illumina HiSeq 2000","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11539276","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5771435","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3741nnn/GSM3741581/suppl/GSM3741581_Z1_clean.fa.gz","circulating exosomes","thyroid cancer with metastasis"
"GSM3741582","Z2: thyroid cancer with metastasis","GSM3741582","Public on May 01 2019","Apr 30 2019","May 15 2019","SRA","1","plasma","Homo sapiens","tissue: thyroid cancer with metastasis","fraction: circulating exosomes","plasma exosomal RNA was isolated from petient with benign thyriod nodule, metiastatic thyroid cancer, non-metastatic thyroid cancer, and healty individuals.","total RNA","The miRNAs were extracted from plasma-isolated exosomes using the miRNeasy Micro Kit per the manufacturer’s protocol","Small RNA libraries were constructed as instructed by the NEBNext Multiplex Small RNA Library Prep Set for Illumina (NEB, Ipswich, MA, USA) with minor modifications. Ten ng of small RNA were used as the starting material. After sequential ligation of the Multiplex 3’ SR Adaptor, hybridization of the reverse transcription primer, and ligation of the Multiplex 5’ SR Adaptor, the RNA-Adaptor complex was reversed transcribed into cDNA. Then the small RNA libraries were amplified and the Illumina compatible Index Primers were incorporated with 10 cycles of PCR amplification. The amplified libraries were resolved on a native 5% acrylamide gel (Bio-rad, Hercules, CA). DNA fragments corresponding to 140 - 160 bp (the size comprising the miRNA inserts plus the 3’ and 5’ adaptors) were recovered in 12 μL of Elution Buffer (QIAGEN) and determined with High Sensitivity DNA Chip on Agilent 2100 bioanalyzer. Absolute quantities of each indexed library were determined by real time qPCR using KAPA Library Quantification Kit according to the manufacture’s protocol.","9606","miRNA","The clustering of the index-coded samples was performed on a cBot Cluster Generation System using TruSeq SR Cluster Kit v3-cBot-HS (Illumia).","After cluster generation, the libraries were sequenced and 50bp single-end reads were generated.","The raw data (raw reads) extracted from FASTQ files were firstly processed through perl and python scripts. In this step, clean data(clean reads) were generated by removing reads containing ploy-N, with 5’ adapter contaminants, without 3’ adapter or the insert tag, containing ploy A or T or G or C and low quality reads from raw data.","Then the clean data were aligned against human miRNA sequences from miRBase (Release 20) and NCBI human genome reference sequences (Release 103) using Bowtie (version 0.12.8) .","miRNA profiling was normalized using read counts of a specific miRNA per million(TPM) mappable miRNA sequences. To find novel miRNAs, the raw data was independently processed by combined use of miRDeep 2 and miREvo. Predicted miRNAs with scores ≥ 2 were considered significant.","GPL11154","Xiaoyi,,Huang","harbinner@hotmail.com","86-451-86298745","Harbin Medical University Cancer Hospital","Haping Road 150","Harbin","Heilongjiang","150081","China","0","Illumina HiSeq 2000","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11539262","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5771436","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3741nnn/GSM3741582/suppl/GSM3741582_Z2_clean.fa.gz","circulating exosomes","thyroid cancer with metastasis"
"GSM3741583","Z3: thyroid cancer with metastasis","GSM3741583","Public on May 01 2019","Apr 30 2019","May 15 2019","SRA","1","plasma","Homo sapiens","tissue: thyroid cancer with metastasis","fraction: circulating exosomes","plasma exosomal RNA was isolated from petient with benign thyriod nodule, metiastatic thyroid cancer, non-metastatic thyroid cancer, and healty individuals.","total RNA","The miRNAs were extracted from plasma-isolated exosomes using the miRNeasy Micro Kit per the manufacturer’s protocol","Small RNA libraries were constructed as instructed by the NEBNext Multiplex Small RNA Library Prep Set for Illumina (NEB, Ipswich, MA, USA) with minor modifications. Ten ng of small RNA were used as the starting material. After sequential ligation of the Multiplex 3’ SR Adaptor, hybridization of the reverse transcription primer, and ligation of the Multiplex 5’ SR Adaptor, the RNA-Adaptor complex was reversed transcribed into cDNA. Then the small RNA libraries were amplified and the Illumina compatible Index Primers were incorporated with 10 cycles of PCR amplification. The amplified libraries were resolved on a native 5% acrylamide gel (Bio-rad, Hercules, CA). DNA fragments corresponding to 140 - 160 bp (the size comprising the miRNA inserts plus the 3’ and 5’ adaptors) were recovered in 12 μL of Elution Buffer (QIAGEN) and determined with High Sensitivity DNA Chip on Agilent 2100 bioanalyzer. Absolute quantities of each indexed library were determined by real time qPCR using KAPA Library Quantification Kit according to the manufacture’s protocol.","9606","miRNA","The clustering of the index-coded samples was performed on a cBot Cluster Generation System using TruSeq SR Cluster Kit v3-cBot-HS (Illumia).","After cluster generation, the libraries were sequenced and 50bp single-end reads were generated.","The raw data (raw reads) extracted from FASTQ files were firstly processed through perl and python scripts. In this step, clean data(clean reads) were generated by removing reads containing ploy-N, with 5’ adapter contaminants, without 3’ adapter or the insert tag, containing ploy A or T or G or C and low quality reads from raw data.","Then the clean data were aligned against human miRNA sequences from miRBase (Release 20) and NCBI human genome reference sequences (Release 103) using Bowtie (version 0.12.8) .","miRNA profiling was normalized using read counts of a specific miRNA per million(TPM) mappable miRNA sequences. To find novel miRNAs, the raw data was independently processed by combined use of miRDeep 2 and miREvo. Predicted miRNAs with scores ≥ 2 were considered significant.","GPL11154","Xiaoyi,,Huang","harbinner@hotmail.com","86-451-86298745","Harbin Medical University Cancer Hospital","Haping Road 150","Harbin","Heilongjiang","150081","China","0","Illumina HiSeq 2000","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11539286","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5771437","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3741nnn/GSM3741583/suppl/GSM3741583_Z3_clean.fa.gz","circulating exosomes","thyroid cancer with metastasis"
"GSM3741584","Z4: thyroid cancer with metastasis","GSM3741584","Public on May 01 2019","Apr 30 2019","May 15 2019","SRA","1","plasma","Homo sapiens","tissue: thyroid cancer with metastasis","fraction: circulating exosomes","plasma exosomal RNA was isolated from petient with benign thyriod nodule, metiastatic thyroid cancer, non-metastatic thyroid cancer, and healty individuals.","total RNA","The miRNAs were extracted from plasma-isolated exosomes using the miRNeasy Micro Kit per the manufacturer’s protocol","Small RNA libraries were constructed as instructed by the NEBNext Multiplex Small RNA Library Prep Set for Illumina (NEB, Ipswich, MA, USA) with minor modifications. Ten ng of small RNA were used as the starting material. After sequential ligation of the Multiplex 3’ SR Adaptor, hybridization of the reverse transcription primer, and ligation of the Multiplex 5’ SR Adaptor, the RNA-Adaptor complex was reversed transcribed into cDNA. Then the small RNA libraries were amplified and the Illumina compatible Index Primers were incorporated with 10 cycles of PCR amplification. The amplified libraries were resolved on a native 5% acrylamide gel (Bio-rad, Hercules, CA). DNA fragments corresponding to 140 - 160 bp (the size comprising the miRNA inserts plus the 3’ and 5’ adaptors) were recovered in 12 μL of Elution Buffer (QIAGEN) and determined with High Sensitivity DNA Chip on Agilent 2100 bioanalyzer. Absolute quantities of each indexed library were determined by real time qPCR using KAPA Library Quantification Kit according to the manufacture’s protocol.","9606","miRNA","The clustering of the index-coded samples was performed on a cBot Cluster Generation System using TruSeq SR Cluster Kit v3-cBot-HS (Illumia).","After cluster generation, the libraries were sequenced and 50bp single-end reads were generated.","The raw data (raw reads) extracted from FASTQ files were firstly processed through perl and python scripts. In this step, clean data(clean reads) were generated by removing reads containing ploy-N, with 5’ adapter contaminants, without 3’ adapter or the insert tag, containing ploy A or T or G or C and low quality reads from raw data.","Then the clean data were aligned against human miRNA sequences from miRBase (Release 20) and NCBI human genome reference sequences (Release 103) using Bowtie (version 0.12.8) .","miRNA profiling was normalized using read counts of a specific miRNA per million(TPM) mappable miRNA sequences. To find novel miRNAs, the raw data was independently processed by combined use of miRDeep 2 and miREvo. Predicted miRNAs with scores ≥ 2 were considered significant.","GPL11154","Xiaoyi,,Huang","harbinner@hotmail.com","86-451-86298745","Harbin Medical University Cancer Hospital","Haping Road 150","Harbin","Heilongjiang","150081","China","0","Illumina HiSeq 2000","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11539285","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5771438","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3741nnn/GSM3741584/suppl/GSM3741584_Z4_clean.fa.gz","circulating exosomes","thyroid cancer with metastasis"
"GSM3741585","Z5: thyroid cancer with metastasis","GSM3741585","Public on May 01 2019","Apr 30 2019","May 15 2019","SRA","1","plasma","Homo sapiens","tissue: thyroid cancer with metastasis","fraction: circulating exosomes","plasma exosomal RNA was isolated from petient with benign thyriod nodule, metiastatic thyroid cancer, non-metastatic thyroid cancer, and healty individuals.","total RNA","The miRNAs were extracted from plasma-isolated exosomes using the miRNeasy Micro Kit per the manufacturer’s protocol","Small RNA libraries were constructed as instructed by the NEBNext Multiplex Small RNA Library Prep Set for Illumina (NEB, Ipswich, MA, USA) with minor modifications. Ten ng of small RNA were used as the starting material. After sequential ligation of the Multiplex 3’ SR Adaptor, hybridization of the reverse transcription primer, and ligation of the Multiplex 5’ SR Adaptor, the RNA-Adaptor complex was reversed transcribed into cDNA. Then the small RNA libraries were amplified and the Illumina compatible Index Primers were incorporated with 10 cycles of PCR amplification. The amplified libraries were resolved on a native 5% acrylamide gel (Bio-rad, Hercules, CA). DNA fragments corresponding to 140 - 160 bp (the size comprising the miRNA inserts plus the 3’ and 5’ adaptors) were recovered in 12 μL of Elution Buffer (QIAGEN) and determined with High Sensitivity DNA Chip on Agilent 2100 bioanalyzer. Absolute quantities of each indexed library were determined by real time qPCR using KAPA Library Quantification Kit according to the manufacture’s protocol.","9606","miRNA","The clustering of the index-coded samples was performed on a cBot Cluster Generation System using TruSeq SR Cluster Kit v3-cBot-HS (Illumia).","After cluster generation, the libraries were sequenced and 50bp single-end reads were generated.","The raw data (raw reads) extracted from FASTQ files were firstly processed through perl and python scripts. In this step, clean data(clean reads) were generated by removing reads containing ploy-N, with 5’ adapter contaminants, without 3’ adapter or the insert tag, containing ploy A or T or G or C and low quality reads from raw data.","Then the clean data were aligned against human miRNA sequences from miRBase (Release 20) and NCBI human genome reference sequences (Release 103) using Bowtie (version 0.12.8) .","miRNA profiling was normalized using read counts of a specific miRNA per million(TPM) mappable miRNA sequences. To find novel miRNAs, the raw data was independently processed by combined use of miRDeep 2 and miREvo. Predicted miRNAs with scores ≥ 2 were considered significant.","GPL11154","Xiaoyi,,Huang","harbinner@hotmail.com","86-451-86298745","Harbin Medical University Cancer Hospital","Haping Road 150","Harbin","Heilongjiang","150081","China","0","Illumina HiSeq 2000","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11539284","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5771439","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3741nnn/GSM3741585/suppl/GSM3741585_Z5_clean.fa.gz","circulating exosomes","thyroid cancer with metastasis"
"GSM3741586","Z6: thyroid cancer with metastasis","GSM3741586","Public on May 01 2019","Apr 30 2019","May 15 2019","SRA","1","plasma","Homo sapiens","tissue: thyroid cancer with metastasis","fraction: circulating exosomes","plasma exosomal RNA was isolated from petient with benign thyriod nodule, metiastatic thyroid cancer, non-metastatic thyroid cancer, and healty individuals.","total RNA","The miRNAs were extracted from plasma-isolated exosomes using the miRNeasy Micro Kit per the manufacturer’s protocol","Small RNA libraries were constructed as instructed by the NEBNext Multiplex Small RNA Library Prep Set for Illumina (NEB, Ipswich, MA, USA) with minor modifications. Ten ng of small RNA were used as the starting material. After sequential ligation of the Multiplex 3’ SR Adaptor, hybridization of the reverse transcription primer, and ligation of the Multiplex 5’ SR Adaptor, the RNA-Adaptor complex was reversed transcribed into cDNA. Then the small RNA libraries were amplified and the Illumina compatible Index Primers were incorporated with 10 cycles of PCR amplification. The amplified libraries were resolved on a native 5% acrylamide gel (Bio-rad, Hercules, CA). DNA fragments corresponding to 140 - 160 bp (the size comprising the miRNA inserts plus the 3’ and 5’ adaptors) were recovered in 12 μL of Elution Buffer (QIAGEN) and determined with High Sensitivity DNA Chip on Agilent 2100 bioanalyzer. Absolute quantities of each indexed library were determined by real time qPCR using KAPA Library Quantification Kit according to the manufacture’s protocol.","9606","miRNA","The clustering of the index-coded samples was performed on a cBot Cluster Generation System using TruSeq SR Cluster Kit v3-cBot-HS (Illumia).","After cluster generation, the libraries were sequenced and 50bp single-end reads were generated.","The raw data (raw reads) extracted from FASTQ files were firstly processed through perl and python scripts. In this step, clean data(clean reads) were generated by removing reads containing ploy-N, with 5’ adapter contaminants, without 3’ adapter or the insert tag, containing ploy A or T or G or C and low quality reads from raw data.","Then the clean data were aligned against human miRNA sequences from miRBase (Release 20) and NCBI human genome reference sequences (Release 103) using Bowtie (version 0.12.8) .","miRNA profiling was normalized using read counts of a specific miRNA per million(TPM) mappable miRNA sequences. To find novel miRNAs, the raw data was independently processed by combined use of miRDeep 2 and miREvo. Predicted miRNAs with scores ≥ 2 were considered significant.","GPL11154","Xiaoyi,,Huang","harbinner@hotmail.com","86-451-86298745","Harbin Medical University Cancer Hospital","Haping Road 150","Harbin","Heilongjiang","150081","China","0","Illumina HiSeq 2000","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11539283","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5771440","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3741nnn/GSM3741586/suppl/GSM3741586_Z6_clean.fa.gz","circulating exosomes","thyroid cancer with metastasis"
"GSM3741587","Z7: thyroid cancer with metastasis","GSM3741587","Public on May 01 2019","Apr 30 2019","May 15 2019","SRA","1","plasma","Homo sapiens","tissue: thyroid cancer with metastasis","fraction: circulating exosomes","plasma exosomal RNA was isolated from petient with benign thyriod nodule, metiastatic thyroid cancer, non-metastatic thyroid cancer, and healty individuals.","total RNA","The miRNAs were extracted from plasma-isolated exosomes using the miRNeasy Micro Kit per the manufacturer’s protocol","Small RNA libraries were constructed as instructed by the NEBNext Multiplex Small RNA Library Prep Set for Illumina (NEB, Ipswich, MA, USA) with minor modifications. Ten ng of small RNA were used as the starting material. After sequential ligation of the Multiplex 3’ SR Adaptor, hybridization of the reverse transcription primer, and ligation of the Multiplex 5’ SR Adaptor, the RNA-Adaptor complex was reversed transcribed into cDNA. Then the small RNA libraries were amplified and the Illumina compatible Index Primers were incorporated with 10 cycles of PCR amplification. The amplified libraries were resolved on a native 5% acrylamide gel (Bio-rad, Hercules, CA). DNA fragments corresponding to 140 - 160 bp (the size comprising the miRNA inserts plus the 3’ and 5’ adaptors) were recovered in 12 μL of Elution Buffer (QIAGEN) and determined with High Sensitivity DNA Chip on Agilent 2100 bioanalyzer. Absolute quantities of each indexed library were determined by real time qPCR using KAPA Library Quantification Kit according to the manufacture’s protocol.","9606","miRNA","The clustering of the index-coded samples was performed on a cBot Cluster Generation System using TruSeq SR Cluster Kit v3-cBot-HS (Illumia).","After cluster generation, the libraries were sequenced and 50bp single-end reads were generated.","The raw data (raw reads) extracted from FASTQ files were firstly processed through perl and python scripts. In this step, clean data(clean reads) were generated by removing reads containing ploy-N, with 5’ adapter contaminants, without 3’ adapter or the insert tag, containing ploy A or T or G or C and low quality reads from raw data.","Then the clean data were aligned against human miRNA sequences from miRBase (Release 20) and NCBI human genome reference sequences (Release 103) using Bowtie (version 0.12.8) .","miRNA profiling was normalized using read counts of a specific miRNA per million(TPM) mappable miRNA sequences. To find novel miRNAs, the raw data was independently processed by combined use of miRDeep 2 and miREvo. Predicted miRNAs with scores ≥ 2 were considered significant.","GPL11154","Xiaoyi,,Huang","harbinner@hotmail.com","86-451-86298745","Harbin Medical University Cancer Hospital","Haping Road 150","Harbin","Heilongjiang","150081","China","0","Illumina HiSeq 2000","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11539282","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5771441","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3741nnn/GSM3741587/suppl/GSM3741587_Z7_clean.fa.gz","circulating exosomes","thyroid cancer with metastasis"
"GSM3741588","Z8: thyroid cancer with metastasis","GSM3741588","Public on May 01 2019","Apr 30 2019","May 15 2019","SRA","1","plasma","Homo sapiens","tissue: thyroid cancer with metastasis","fraction: circulating exosomes","plasma exosomal RNA was isolated from petient with benign thyriod nodule, metiastatic thyroid cancer, non-metastatic thyroid cancer, and healty individuals.","total RNA","The miRNAs were extracted from plasma-isolated exosomes using the miRNeasy Micro Kit per the manufacturer’s protocol","Small RNA libraries were constructed as instructed by the NEBNext Multiplex Small RNA Library Prep Set for Illumina (NEB, Ipswich, MA, USA) with minor modifications. Ten ng of small RNA were used as the starting material. After sequential ligation of the Multiplex 3’ SR Adaptor, hybridization of the reverse transcription primer, and ligation of the Multiplex 5’ SR Adaptor, the RNA-Adaptor complex was reversed transcribed into cDNA. Then the small RNA libraries were amplified and the Illumina compatible Index Primers were incorporated with 10 cycles of PCR amplification. The amplified libraries were resolved on a native 5% acrylamide gel (Bio-rad, Hercules, CA). DNA fragments corresponding to 140 - 160 bp (the size comprising the miRNA inserts plus the 3’ and 5’ adaptors) were recovered in 12 μL of Elution Buffer (QIAGEN) and determined with High Sensitivity DNA Chip on Agilent 2100 bioanalyzer. Absolute quantities of each indexed library were determined by real time qPCR using KAPA Library Quantification Kit according to the manufacture’s protocol.","9606","miRNA","The clustering of the index-coded samples was performed on a cBot Cluster Generation System using TruSeq SR Cluster Kit v3-cBot-HS (Illumia).","After cluster generation, the libraries were sequenced and 50bp single-end reads were generated.","The raw data (raw reads) extracted from FASTQ files were firstly processed through perl and python scripts. In this step, clean data(clean reads) were generated by removing reads containing ploy-N, with 5’ adapter contaminants, without 3’ adapter or the insert tag, containing ploy A or T or G or C and low quality reads from raw data.","Then the clean data were aligned against human miRNA sequences from miRBase (Release 20) and NCBI human genome reference sequences (Release 103) using Bowtie (version 0.12.8) .","miRNA profiling was normalized using read counts of a specific miRNA per million(TPM) mappable miRNA sequences. To find novel miRNAs, the raw data was independently processed by combined use of miRDeep 2 and miREvo. Predicted miRNAs with scores ≥ 2 were considered significant.","GPL11154","Xiaoyi,,Huang","harbinner@hotmail.com","86-451-86298745","Harbin Medical University Cancer Hospital","Haping Road 150","Harbin","Heilongjiang","150081","China","0","Illumina HiSeq 2000","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11539281","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5771442","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3741nnn/GSM3741588/suppl/GSM3741588_Z8_clean.fa.gz","circulating exosomes","thyroid cancer with metastasis"
